Avoiding Tolerance Against Prostatic Antigens With Subdominant Peptide Epitopes

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of immunotherapy

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002371-200105000-00007PMID 11394501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of CTL Responses by Simultaneous Administration of Liposomal Peptide Vaccine with Anti-CD40 and Anti-CTLA-4 mAb1

  2000cited by this paper
• Repeated Administration of Cytosine-Phosphorothiolated Guanine-Containing Oligonucleotides Together with Peptide/Protein Immunization Results in Enhanced CTL Responses with Anti-Tumor Activity1

  2000cited by this paper
• The role of CpG motifs in innate immunity.

  2000cited by this paper
• Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.

  1999cited by this paper
• Oligodeoxynucleotides Containing Palindrome Sequences with Internal 5′-CpG-3′ Act Directly on Human NK and Activated T Cells to Induce IFN-γ Production In Vitro

  1999cited by this paper
• Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.

  1998cited by this paper
• FLT‐3 ligand mobilizes hematopoietic primitive and committed progenitor cells into blood in mice

  1998cited by this paper
• Cancer vaccines based on the identification of genes encoding cancer regression antigens.

  1997cited by this paper
• Biomarker expression in prostatic intraepithelial neoplasia.

  1996influential reference
• Metastatic prostate cancer in a transgenic mouse.

  1996cited by this paper
• Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen

  1995cited by this paper
• Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen.

  1995cited by this paper
• Prostate cancer in a transgenic mouse.

  1995cited by this paper
• Tumor markers in prostate cancer

  1992influential reference
• Tumor eradication by adoptive transfer of cytotoxic T lymphocytes.

  1992cited by this paper
• Carcinoma of the prostate.

  1991cited by this paper
• A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

  1986cited by this paper
• Cytolytic T lymphocytes.

  1983cited by this paper
• Carcinoma of the prostate.

  1978cited by this paper

• Antigens

  2021cites this paper
• A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses

  2018cites this paper
• Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination

  2017cites this paper
• PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination

  2017cites this paper
• This information is current as Clones To Relieve Immunodomination SubdominantPreventing Fratricidal Death of T Cell Responses by + in Anticancer CD 8 PD-1 Blockade Promotes Epitope Spreading

  2017cites this paper
• Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.

  2014cites this paper
• Oligodeoxynucleotide-CpG in Mice Protein Using Prion Protein Peptides Plus Breaking Immune Tolerance to the Prion

  2013cites this paper
• Polyclonal CD8+ T Cell Repertoire The Impact of Self-Tolerance on the

  2013cites this paper
• Molecular and Genetic Medicine

  2013cites this paper
• Vaccination Strategies in NSCLC Patients

  2013cites this paper
• An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform

  2012cites this paper
• Modification of a Tumor Antigen Determinant To Improve Peptide/MHC Stability Is Associated with Increased Immunogenicity and Cross-Priming a Larger Fraction of CD8+ T Cells

  2012cites this paper
• Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.

  2012influential citation
• Fraction of CD 8 LargerImmunogenicity and Cross-Priming a Stability Is Associated with Increased Determinant To Improve Peptide / MHC Modification of a Tumor Antigen and

  2012cites this paper
• This information is current as Immune Response Players in the Vaccine-Induced Antitumor Nondominant CD 8 T Cells Are Active

  2011cites this paper
• Nondominant CD8 T Cells Are Active Players in the Vaccine-Induced Antitumor Immune Response

  2011cites this paper
• CD8+ T-cell cross-competition is governed by peptide–MHC class I stability

  2011cites this paper
• Optimization of PLGA microspheres for immunotherapy of tumors in the mouse model

  2010cites this paper
• Cancer Biomarker Discovery: The Entropic Hallmark

  2010cites this paper
• Optimised electroporation mediated DNA vaccination for treatment of prostate cancer

  2010cites this paper
• Priming and Activation of Human Ovarian and Breast Cancer-specific CD8+ T Cells by Polyvalent Listeria monocytogenes-based Vaccines

  2009cites this paper
• Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.

  2009cites this paper
• Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer

  2008cites this paper
• Activation Carcinoma Requires In Vivo T Cell TCR Gene Therapy of Spontaneous Prostate

  2008cites this paper
• TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation1

  2008cites this paper
• Antigens for cancer immunotherapy.

  2008cites this paper
• From cancer immunosurveillance to cancer immunotherapy

  2007cites this paper
• Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.

  2007cites this paper
• A Phase I Study of the Optimized Cryptic Peptide TERT572Y in Patients with Advanced Malignancies

  2006cites this paper
• Epitope Immunization against an Immunorecessive Progression following Secondary DiseaseAdvanced-Stage Tumors and Delay of T Cells in + Accumulation of CD 8

  2006cites this paper
• Promises and Limitations of Murine Models in the Development of Anticancer T-Cell Vaccines

  2006cites this paper
• MHC transfer from APC to T cells following antigen recognition.

  2006cites this paper
• Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen

  2006cites this paper
• Accumulation of CD8+ T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope1

  2006cites this paper
• Induction of t-cell responses against PSA by plasmid DNA immunization

  2005cites this paper
• Identification of an immunodominant H‐2Db‐restricted CTL epitope of human PSA

  2005cites this paper
• Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles.

  2005cites this paper
• Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization

  2005cites this paper
• INDUCTION OF T-CELL RESPONSES AGAINST PSA BY

  2005cites this paper
• Immunotherapy for Human Cancer

  2004cites this paper
• Co-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growth

  2004cites this paper
• T-Cell Stimulation by Melanoma RNA-Pulsed Dendritic Cells

  2004cites this paper
• Breaking Immune Tolerance to the Prion Protein Using Prion Protein Peptides Plus Oligodeoxynucleotide-CpG in Mice1

  2004cites this paper
• A conjugate of a tumor-targeting ligand and a T cell costimulatory antibody to treat brain tumors.

  2004cites this paper
• Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue‐specific vaccine candidate

  2004cites this paper
• Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA‐A*0201‐restricted epitopes

  2004cites this paper
• In Vivo Expansion of the Residual Tumor Antigen-Specific CD8+ T Lymphocytes That Survive Negative Selection in Simian Virus 40 T-Antigen-Transgenic Mice

  2004cites this paper
• CpG motifs: the active ingredient in bacterial extracts?

  2003cites this paper
• Epitope dominance, competition and T cell affinity maturation.

  2003cites this paper
• Identification and targeting of tumor escape mechanisms: a new hope for cancer therapy?

  2003cites this paper
• Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.

  2003cites this paper
• Liposomal Delivery of CTL Epitopes to Dendritic Cells

  2002cites this paper
• Antigens Overexpressed in Solid Tumors Shaping the Repertoire of T Cells Specific for Important Role for Clonal Deletion in Adenocarcinoma of Mouse Prostate Mice: An Antigen-Specific T Cells in the Transgenic Clonal Deletion of Simian Virus 40 Large T

  2002cites this paper
• Clonal Deletion of Simian Virus 40 Large T Antigen-Specific T Cells in the Transgenic Adenocarcinoma of Mouse Prostate Mice: An Important Role for Clonal Deletion in Shaping the Repertoire of T Cells Specific for Antigens Overexpressed in Solid Tumors1

  2002cites this paper
• compartmentexpansion of naive and memory T lymphocytes in a full T-cell Creating space : an antigen-independent , CpG-induced peripheral

  2002cites this paper
• HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy1

  2002cites this paper
• Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment.

  2002cites this paper
• Hierarchy, tolerance, and dominance in the antitumor T-cell response.

  2001cites this paper
• Hierarchy, Tolerance, and Dominance in the Antitumor T-Cell Response.

  2001influential citation